Dr Khan on Optimizing Local Therapy Using MRI and a 12-Gene Expression Assay in DCIS
Seema A. Khan, MD, discusses 5-year clinical outcomes from the ECOG-ACRIN E4112 trial, which is evaluating the use of MRI and a 12-gene expression assay to optimize local therapy for patients with ductal carcinoma in situ.
Seemaa Khan Northwestern University Feinberg School Of Medicine Bluhm Family Professor Of Cancer Research Optimizing Local Therapy Using Gene Expression Assay Partnership With
Source: onclive.com